PR Boasts, CEO Balks: One AI Firm’s Quest to Prove Value
Ada Health's CEO declined to comment on a bold PR pitch. He contends the company is profitable and at least one health system executive is satisfied with Ada's AI symptom checker.
Ada Health's CEO declined to comment on a bold PR pitch. He contends the company is profitable and at least one health system executive is satisfied with Ada's AI symptom checker.
Ada Health recently announced that Jefferson Health is deploying its technology across its entire enterprise as part of a digital front door initiative. The Berlin-based company’s AI-powered symptom assessment and care navigation tools helps health systems achieve a robust digital front door, which means staff members don’t have to spend as much time triaging patients or helping them navigate the process of finding care.
The company announced this week that its AI-powered symptom assessment and care navigation platform is now available in the Epic App Orchard. Jeff Cutler, Ada's chief commercial officer, and Scott Fannin, the company's vice president of enterprise product management, discussed the announcement in a sit-down interview at the Global Health Conference & Exhibition in Orlando.
Ada Health closed its Series B round after a $30 million extension round. International investors Farallon Capital, Red River West and Bertelsmann Investments provided the additional funds. This follows an initial Series B raise of $90 million last May, which was led by Bayer's investment arm.
Leaps by Bayer led a $90 million investment round into Ada, a German digital health startup with an AI-based symptom checker. As part of the deal, the two companies are also striking a broader strategic partnership.